Discovery 2010

Event date 18 September 2010 – 20 September 2010

Location Red Rock Casino Resort Spa, Las Vegas, USA

Teodor Aastrup, CEO , Attana AB will be presenting on: Kinetics on cells – bridging the gap between traditional biosensors and cell-based assays The development of new pharmaceutical antibodies is a long and expensive process with sharply increasing costs during clinical trials. Widespread technologies to measure molecular interactions using purified target and ligand are powerful, but often oversimplify the interaction. This is particularly true for membrane proteins which need a membrane environment to retain their biological activity. At the same time, bioassays measure the biological effects but do not give much information regarding the dynamics of interactions. This leaves a gap in the information base which can be filled by molecular interaction measurements directly on cells. Thus, an immense improvement within the field would be to measure the true drug interaction with the native target in its biological context, the cell. Studying the interaction towards the target in its native context promises better estimates of efficacy, dosing and safety, lowering the reported 50% fall-out in Phase III. The Attana Cell™ 200 is a QCM based biosensor that provides highly informative data about drug candidates in preclinical stage, thus improving selection and reducing the risk of late failures. Two typical examples where the Attana Cell 200 proved to be beneficial will be presented; 1) study of a glycoprotein to be used as a diagnostic tool for early detection of metastatic colorectal cancer, 2) characterization of modified Herceptin® designed for targeted immunotherapy in cases of breast and ovarian carcinomas. Dr. Staffan Grenklo will also be available for meetings with conference participants. Event webpage: http://www.thediscoverysummit.com/

Categories

  • qcm
  • kinetic on cells
  • attana cell 200
  • cells
  • biosensor

Related content

Fight against cancer - Attana's collaborator interviewed

Attana's collaborator at Gothenburg University, Dr. Sture Lindegren, is interviewed about a possible new cure for ovarian cancers. Using the Attana Cell 200 instrument, Dr. Lindegren and his team are testing antibodies as carriers of radionuclide that target cancer cells directly instead of affecting the whole body as current cancer therapies do.

PEGS 2010 with Attana!

We are happy to have met so many industry people during the Protein Engineering Summit 2010 in Boston last week, and if you were there but didn't get the chance to taste our exquisite espresso you are welcome to stop by our booth during our upcoming events!

Attana's Story told by CEO and co-founder Dr. Teodor Aastrup

When we founded Attana in 2002, we had a dream of creating a tool that could mimic reality. We were set to do this by developing an instrument capable of measuring biological interactions exactly as the actual events in the human body.

Biotech companies - Ways to work more efficiently

Ernst & Young recently released their 24th annual report Beyond borders: global biotechnology report 2010, presenting, among other things, five guiding principles for biotech companies working in the new economy where funding is scarce and customers careful:

Universities and Innovation

We consider it strategically important to keep collaborating with our customers, university researchers in particular, to stay on top and keep getting inspired.

Attana - inspiring health

At Attana we aim at improving health in society by helping our customers in their scientific research, whether they are university researchers or pharmaceutical companies developing efficient treatment against severe diseases. However, another way to stay healthy is to eat wisely and exercise, and we Attanians exercise in abundance. For instance, several years in a row Attana has...

Related events

Recombinant Antibodies: Covagen AG presents the Fynomer technology

Event date 13 June 2010 – 17 June 2010

Location The Crowne Plaza Berlin City Centre, Germany

Evaluating Novel Technologies for Cell Based Screening

Event date 14 June 2010 – 15 June 2010

Location Sheraton Philadelphia City Center, USA

Kinetic Concepts Course - Attana Step II

Event date 26 October 2010 – 27 October 2010

Location The Massachusetts Institute of Technology, Boston, MA, USA

Het Instrument 2010 - The sound of technology

Event date 27 September 2010 – 30 September 2010

Location Amsterdam, The Netherlands

Next Generation Protein Therapeutics

Event date 27 September 2010 – 28 September 2010

Location Sheraton Brussels Hotel Brussels, Belgium